This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Remegen Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Qiaohua Hou: Innovator in Antibody-Drug Conjugates
Introduction
Qiaohua Hou is a notable inventor in the field of targeted therapeutic drugs. He has made significant contributions to the development of antibody-drug conjugates, which are crucial in the treatment of tumors. His innovative work focuses on improving the uniformity and stability of these conjugates.
Latest Patents
Qiaohua Hou holds a patent titled "A Linker For Antibody-Drug Conjugates And Its Use." This invention addresses the challenges associated with the poor uniformity of coupled products in antibody-drug conjugates. The linker he developed is capable of coupling with thiol or amino groups on antibodies or their functional fragments. This capability allows for the coupling of multiple thiol groups, resulting in a uniform and structurally stable product.
Career Highlights
Qiaohua Hou is currently associated with Remegen Co., Ltd., where he continues to advance research in the field of antibody-drug conjugates. His work has the potential to significantly impact cancer treatment by providing more effective therapeutic options.
Collaborations
He has collaborated with notable colleagues, including Changjiang Huang and Hui Ye, to further enhance the development of innovative therapeutic solutions.
Conclusion
Qiaohua Hou's contributions to the field of antibody-drug conjugates exemplify the importance of innovation in medical research. His work not only addresses existing challenges but also paves the way for future advancements in targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile